Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology
A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle regulator CDKN1B as its highest-af...